Cargando…
Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study
OBJECTIVE: We aimed to understand the molecular pathways affected by bortezomib and arsenic trioxide treatment on myelomonocytoid cell line P39. MATERIALS AND METHODS: Oligonucleotide microarray platforms were used for gene expression and pathway analysis. Confirmation studies were performed using q...
Autores principales: | Savlı, Hakan, Galimberti, Sara, Sünnetçi, Deniz, Canestraro, Martina, Palumbo, Giuseppe, Nagy, Balint, Raimondo, Francesco Di, Petrini, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563195/ https://www.ncbi.nlm.nih.gov/pubmed/25913414 http://dx.doi.org/10.4274/tjh.2014.0058 |
Ejemplares similares
-
Effects of curcumin on global gene expression profiles in the highly invasive human breast carcinoma cell line MDA-MB 231: A gene network-based microarray analysis
por: CINE, NACI, et al.
Publicado: (2013) -
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study
por: Galimberti, Sara, et al.
Publicado: (2012) -
Arsenic trioxide rewires mantle cell lymphoma response to bortezomib
por: Zhao, Ling-Ling, et al.
Publicado: (2015) -
Arsenic trioxide and triptolide synergistically induce apoptosis in the SKM-1 human myelodysplastic syndrome cell line
por: Hua, Hai-Ying, et al.
Publicado: (2016) -
The effect of first chromosome long arm duplication on survival of endometrial carcinoma
por: Sever, Erman, et al.
Publicado: (2014)